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Letters to the Editor
Tissue Doppler Imaging:
Diagnostic and Prognostic Value
The paper by Yu et al. (1) in the Journal summarized the
applications of tissue Doppler imaging (TDI). However, we
consider additional clinical applications to be very important.
We have used TDI routinely for after-transplant monitoring since
1998. Our studies proved TDI’s reliability for early detection of
acute rejection and transplant coronary artery disease (TxCAD)
and showed that serial TDI can spare patients unnecessary and
distressing routine invasive examinations (2,3). Tissue Doppler
imaging also appeared reliable for prognostic estimations after
heart transplantation and for the evaluation of rejection severity
and guidance of antirejection therapy (2,3). Recently we showed
that TDI can also be helpful in evaluations of myocardial recovery
during mechanical unloading after ventricular assist device (VAD)
implantation (4).
We do not agree with Yu et al. (1) that myocardial deformation
imaging is not ready for routine clinical use. Recently, Perk et al.
(5) emphasized the clinical reliability of the method. We use
2-dimensional strain imaging routinely for patients’ evaluation
before and after coronary surgery and also for noninvasive moni-
toring of allograft function after heart transplantation. Addition-
ally, 2-dimensional strain imaging is our method of choice for
patient selection for surgical ventricular restoration (SVR) after
severe myocardial infarction. We found that the systolic dyssyn-
chrony indexes and global strain rate are reliable for evaluation of
myocardial functional changes during postoperative reverse re-
modeling processes after SVR. The 2-dimensional strain method
also improved our ability to evaluate cardiac recovery after VAD
implantation and was decisive for the decision to wean 5 patients
from their assist devices. In heart-transplanted patients, we found
that systolic strain dyssynchrony and dyssynergy indexes are more
useful than pulsed-wave TDI parameters for differentiation be-
tween angiographic TxCAD with and without proximal focal
stenoses.
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